Full length MFGE8 has also been investigated in the context of CAA pathology; it was found that it was overexpressed in CAA vessels, colocalizes with vascular Aβ deposits, and is decreased in CSF of CAA patients, compared to both AD and controls [25]. This evidence concerns the gene MFGE8 and Alzheimer disease.